1. Home
  2. COLL vs HCSG Comparison

COLL vs HCSG Comparison

Compare COLL & HCSG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COLL
  • HCSG
  • Stock Information
  • Founded
  • COLL 2002
  • HCSG 1976
  • Country
  • COLL United States
  • HCSG United States
  • Employees
  • COLL N/A
  • HCSG N/A
  • Industry
  • COLL Biotechnology: Pharmaceutical Preparations
  • HCSG Assisted Living Services
  • Sector
  • COLL Health Care
  • HCSG Health Care
  • Exchange
  • COLL Nasdaq
  • HCSG Nasdaq
  • Market Cap
  • COLL 958.8M
  • HCSG 1.1B
  • IPO Year
  • COLL 2015
  • HCSG N/A
  • Fundamental
  • Price
  • COLL $38.32
  • HCSG $15.83
  • Analyst Decision
  • COLL Strong Buy
  • HCSG Strong Buy
  • Analyst Count
  • COLL 4
  • HCSG 4
  • Target Price
  • COLL $44.25
  • HCSG $16.25
  • AVG Volume (30 Days)
  • COLL 427.8K
  • HCSG 717.0K
  • Earning Date
  • COLL 08-07-2025
  • HCSG 10-22-2025
  • Dividend Yield
  • COLL N/A
  • HCSG N/A
  • EPS Growth
  • COLL N/A
  • HCSG N/A
  • EPS
  • COLL 1.06
  • HCSG 0.14
  • Revenue
  • COLL $707,007,000.00
  • HCSG $1,772,114,000.00
  • Revenue This Year
  • COLL $22.23
  • HCSG $8.88
  • Revenue Next Year
  • COLL $2.78
  • HCSG $5.09
  • P/E Ratio
  • COLL $36.58
  • HCSG $111.34
  • Revenue Growth
  • COLL 22.61
  • HCSG 5.17
  • 52 Week Low
  • COLL $23.23
  • HCSG $9.13
  • 52 Week High
  • COLL $42.29
  • HCSG $15.94
  • Technical
  • Relative Strength Index (RSI)
  • COLL 59.51
  • HCSG 65.14
  • Support Level
  • COLL $38.00
  • HCSG $15.45
  • Resistance Level
  • COLL $39.78
  • HCSG $15.93
  • Average True Range (ATR)
  • COLL 0.97
  • HCSG 0.38
  • MACD
  • COLL -0.18
  • HCSG 0.01
  • Stochastic Oscillator
  • COLL 38.72
  • HCSG 86.81

About COLL Collegium Pharmaceutical Inc.

Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.

About HCSG Healthcare Services Group Inc.

Healthcare Services Group Inc is a provider of housekeeping and facility management services to the healthcare industry. The company operates two business segments, both contributing roughly equally to the company's revenue: Housekeeping, laundry, linen, and other services; and Dietary department services. Housekeeping includes management of clients' housekeeping departments, cleaning, disinfecting and sanitizing, laundry, bed linen, and uniform services. Dietary consists of food purchasing, meal preparation, and providing dietitian consulting services. Its clients are nursing homes, retirement complexes, rehabilitation centers, and hospitals in the United States of America.

Share on Social Networks: